These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

345 related articles for article (PubMed ID: 19040209)

  • 21. B4 androgen ablation: attacking the prostate cancer stem cell.
    Wicha MS
    J Clin Invest; 2013 Feb; 123(2):563-5. PubMed ID: 23348735
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Cancer stem cells in breast and prostate: Fact or fiction?
    Sampayo RG; Bissell MJ
    Adv Cancer Res; 2019; 144():315-341. PubMed ID: 31349902
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Androgen deprivation causes epithelial-mesenchymal transition in the prostate: implications for androgen-deprivation therapy.
    Sun Y; Wang BE; Leong KG; Yue P; Li L; Jhunjhunwala S; Chen D; Seo K; Modrusan Z; Gao WQ; Settleman J; Johnson L
    Cancer Res; 2012 Jan; 72(2):527-36. PubMed ID: 22108827
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Prostate cancer stem cells: from theory to practice.
    Adamowicz J; Pakravan K; Bakhshinejad B; Drewa T; Babashah S
    Scand J Urol; 2017 Apr; 51(2):95-106. PubMed ID: 28635565
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Androgen signaling is essential for development of prostate cancer initiated from prostatic basal cells.
    He Y; Hooker E; Yu EJ; Cunha GR; Liao L; Xu J; Earl A; Wu H; Gonzalgo ML; Sun Z
    Oncogene; 2019 Mar; 38(13):2337-2350. PubMed ID: 30510232
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Prostate stem cells and prostate cancer.
    Lawson DA; Xin L; Lukacs R; Xu Q; Cheng D; Witte ON
    Cold Spring Harb Symp Quant Biol; 2005; 70():187-96. PubMed ID: 16869753
    [TBL] [Abstract][Full Text] [Related]  

  • 27. New insights into prostate cancer stem cells.
    Chen X; Rycaj K; Liu X; Tang DG
    Cell Cycle; 2013 Feb; 12(4):579-86. PubMed ID: 23370446
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Enrichment of putative prostate cancer stem cells after androgen deprivation: upregulation of pluripotency transactivators concurs with resistance to androgen deprivation in LNCaP cell lines.
    Seiler D; Zheng J; Liu G; Wang S; Yamashiro J; Reiter RE; Huang J; Zeng G
    Prostate; 2013 Sep; 73(13):1378-90. PubMed ID: 23728788
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Does an inability to eradicate normal stem cells preclude the cure of some cancers?
    Anderson KM; Bonomi P; Harris JE
    Med Hypotheses; 1996 Jul; 47(1):31-4. PubMed ID: 8819113
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The molecular and cellular origin of human prostate cancer.
    Packer JR; Maitland NJ
    Biochim Biophys Acta; 2016 Jun; 1863(6 Pt A):1238-60. PubMed ID: 26921821
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Aging of the prostate epithelial stem/progenitor cell.
    Zenzmaier C; Untergasser G; Berger P
    Exp Gerontol; 2008 Nov; 43(11):981-5. PubMed ID: 18639623
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The Efflux Transporter ABCG2 Maintains Prostate Stem Cells.
    Sabnis NG; Miller A; Titus MA; Huss WJ
    Mol Cancer Res; 2017 Feb; 15(2):128-140. PubMed ID: 27856956
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Prostate cancer stem cells: are they androgen-responsive?
    Oldridge EE; Pellacani D; Collins AT; Maitland NJ
    Mol Cell Endocrinol; 2012 Sep; 360(1-2):14-24. PubMed ID: 21802490
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Identification, characterization, and biological relevance of prostate cancer stem cells from clinical specimens.
    Kasper S
    Urol Oncol; 2009; 27(3):301-3. PubMed ID: 19414117
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Primary cell cultures as models of prostate cancer development.
    Peehl DM
    Endocr Relat Cancer; 2005 Mar; 12(1):19-47. PubMed ID: 15788637
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Establishment of prostate cancer spheres from a prostate cancer cell line after phenethyl isothiocyanate treatment and discovery of androgen-dependent reversible differentiation between sphere and neuroendocrine cells.
    Chen Y; Cang S; Han L; Liu C; Yang P; Solangi Z; Lu Q; Liu D; Chiao JW
    Oncotarget; 2016 May; 7(18):26567-79. PubMed ID: 27034170
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Prostate carcinoma and stem cells.
    Antón Aparicio LM; Cassinello Espinosa J; García Campelo R; Gómez Veiga F; Díaz Prado S; Aparicio Gallego G
    Clin Transl Oncol; 2007 Feb; 9(2):66-76. PubMed ID: 17329217
    [TBL] [Abstract][Full Text] [Related]  

  • 38. The marrow niche controls the cancer stem cell phenotype of disseminated prostate cancer.
    Shiozawa Y; Berry JE; Eber MR; Jung Y; Yumoto K; Cackowski FC; Yoon HJ; Parsana P; Mehra R; Wang J; McGee S; Lee E; Nagrath S; Pienta KJ; Taichman RS
    Oncotarget; 2016 Jul; 7(27):41217-41232. PubMed ID: 27172799
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Early human prostate adenocarcinomas harbor androgen-independent cancer cells.
    Fiñones RR; Yeargin J; Lee M; Kaur AP; Cheng C; Sun P; Wu C; Nguyen C; Wang-Rodriguez J; Meyer AN; Baird SM; Donoghue DJ; Haas M
    PLoS One; 2013; 8(9):e74438. PubMed ID: 24086346
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Stem cells in prostate cancer: resolving the castrate-resistant conundrum and implications for hormonal therapy.
    Sharifi N; Kawasaki BT; Hurt EM; Farrar WL
    Cancer Biol Ther; 2006 Aug; 5(8):901-6. PubMed ID: 16855379
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 18.